|
May 28
|
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
|
|
May 28
|
Boston Scientific ends TAVR sales; J&J shares Monarch robot data
|
|
May 27
|
1 Top Dividend Stock to Buy for a Lifetime of Passive Income
|
|
May 25
|
US FDA Votes in Favor of Benefit-Risk Profile of Johnson & Johnson’s DARZALEX FASPRO
|
|
May 24
|
Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyond
|
|
May 17
|
Trump administration not backing down on Big Pharma pressure campaign
|
|
May 17
|
3 Magnificent Stocks That Are Passive Income Machines
|
|
May 16
|
Jim Cramer Notes That “People Are Staying Away From” Johnson & Johnson
|
|
May 15
|
Why Is Johnson & Johnson (JNJ) Down 4.9% Since Last Earnings Report?
|
|
May 14
|
Halozyme, J&J slide as analyst cuts rating on CMS draft guidance
|
|
May 14
|
The Smartest Dividend Stocks to Buy With $5,000 Right Now
|
|
May 13
|
Is Johnson & Johnson (JNJ) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?
|
|
May 13
|
Big Pharma Counted on This Loophole. It May Be Closing.
|
|
May 13
|
Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News
|
|
May 13
|
With the breakneck speed of cancer breakthroughs, oncologists feel left behind. Can Big Pharma chime in?
|
|
May 12
|
S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'
|
|
May 12
|
HistoSonics secures first insurance coverage for histotripsy system
|
|
May 12
|
Trump expected to sign order to slash US drug prices
|
|
May 12
|
Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers
|
|
May 12
|
US-China trade truce, April CPI, drug prices: 3 Things
|